{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T17:56:45Z","timestamp":1776103005811,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,3,10]],"date-time":"2015-03-10T00:00:00Z","timestamp":1425945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10067-015-2899-9","type":"journal-article","created":{"date-parts":[[2015,3,8]],"date-time":"2015-03-08T22:44:16Z","timestamp":1425854656000},"page":"1025-1030","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Low-molecular-weight adiponectin is more closely associated with disease activity of rheumatoid arthritis than other adiponectin multimeric forms"],"prefix":"10.1007","volume":"34","author":[{"given":"Ping","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cui-li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-qi","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,10]]},"reference":[{"key":"2899_CR1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/annrheumdis-2012-203130","volume":"73","author":"JA Nies van","year":"2014","unstructured":"van Nies JA, Krabben A, Schoones JW, Huizinga TW, Kloppenburg M, van der Helm-van Mil AH (2014) What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review. Ann Rheum Dis 73:861\u201370","journal-title":"Ann Rheum Dis"},{"key":"2899_CR2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3899\/jrheum.130888","volume":"41","author":"IR Klein-Wieringa","year":"2014","unstructured":"Klein-Wieringa IR, Andersen SN, Herb-van Toorn L, Kwekkeboom JC, van der Helm-van Mil AH, Meulenbelt I et al (2014) Are baseline high molecular weight adiponectin levels associated with radiographic progression in rheumatoid arthritis and osteoarthritis? J Rheumatol 41:853\u20137","journal-title":"J Rheumatol"},{"key":"2899_CR3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.12965\/jer.140100","volume":"10","author":"S Lee","year":"2014","unstructured":"Lee S, Kwak HB (2014) Role of adiponectin in metabolic and cardiovascular disease. J Exerc Rehabil 10:54\u201359","journal-title":"J Exerc Rehabil"},{"key":"2899_CR4","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.atherosclerosis.2014.01.051","volume":"233","author":"S Lim","year":"2014","unstructured":"Lim S, Quon MJ, Koh KK (2014) Modulation of adiponectin as a potential therapeutic strategy. Atherosclerosis 233:721\u20138","journal-title":"Atherosclerosis"},{"key":"2899_CR5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.beem.2013.06.008","volume":"28","author":"KJ Mather","year":"2014","unstructured":"Mather KJ, Goldberg RB (2014) Clinical use of adiponectin as a marker of metabolic dysregulation. Best Pract Res Clin Endocrinol Metab 28:107\u201317","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2899_CR6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3892\/mmr.2013.1764","volume":"9","author":"KS Kim","year":"2014","unstructured":"Kim KS, Choi HM, Ji HI, Song R, Yang HI, Lee SK et al (2014) Serum adipokine levels in rheumatoid arthritis patients and their contributions to the resistance to treatment. Mol Med Rep 9:255\u201360","journal-title":"Mol Med Rep"},{"key":"2899_CR7","author":"PH Dessein","year":"2013","unstructured":"Dessein PH, Norton GR, Badenhorst M, Woodiwiss AJ, Solomon A (2013) Rheumatoid arthritis impacts on the independent relationships between circulating adiponectin concentrations and cardiovascular metabolic risk. Mediators Inflamm. doi: 10.1155\/2013\/461849","journal-title":"Mediators Inflamm"},{"key":"2899_CR8","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00296-013-2714-3","volume":"33","author":"SH El-Hini","year":"2013","unstructured":"El-Hini SH, Mohamed FI, Hassan AA, Ali F, Mahmoud A, Ibraheem HM (2013) Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients. Rheumatol Int 33:2283\u20139","journal-title":"Rheumatol Int"},{"key":"2899_CR9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1590\/S0482-50042012000200011","volume":"52","author":"S Barbosa Vde","year":"2012","unstructured":"Barbosa Vde S, R\u00eago J, Ant\u00f4nio da Silva N (2012) Possible role of adipokines in systemic lupus erythematosus and rheumatoid arthritis. Rev Bras Reumatol 52:278\u201387","journal-title":"Rev Bras Reumatol"},{"key":"2899_CR10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00394-012-0370-0","volume":"51","author":"R Krysiak","year":"2012","unstructured":"Krysiak R, Handzlik-Orlik G, Okopien B (2012) The role of adipokines in connective tissue diseases. Eur J Nutr 51:513\u201328","journal-title":"Eur J Nutr"},{"key":"2899_CR11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.exger.2013.01.015","volume":"48","author":"W Bik","year":"2013","unstructured":"Bik W, Baranowska-Bik A, Wolinska-Witort E, Kalisz M, Broczek K, Mossakowska M et al (2013) Assessment of adiponectin and its isoforms in Polish centenarians. Exp Gerontol 48:401\u20137","journal-title":"Exp Gerontol"},{"key":"2899_CR12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/jdi.12133","volume":"5","author":"L Foucan","year":"2014","unstructured":"Foucan L, Maimaitiming S, Larifla L, Hedreville S, Deloumeaux J, Joannes MO et al (2014) Adiponectin gene variants, adiponectin isoforms and cardiometabolic risk in type 2 diabetic patients. J Diabetes Investig 5:192\u20138","journal-title":"J Diabetes Investig"},{"key":"2899_CR13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1758-5996-5-20","volume":"5","author":"F Crispim","year":"2013","unstructured":"Crispim F, Vendramini MF, Japanese-Brazilian Diabetes Study Group, Mois\u00e9s RS (2013) Adiponectin complexes composition in Japanese-Brazilians regarding their glucose tolerance status. Diabetol Metab Syndr 5:20","journal-title":"Diabetol Metab Syndr"},{"key":"2899_CR14","first-page":"711","volume":"32","author":"B Baranowska","year":"2011","unstructured":"Baranowska B, Kochanowski J, Grudniak M, Baranowska-Bik A, Wolinska-Witort E, Martynska L et al (2011) Decreased total serum adiponectin and its isoforms in women with acute ischemic stroke. Neuro Endocrinol Lett 32:711\u20135","journal-title":"Neuro Endocrinol Lett"},{"key":"2899_CR15","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.2337\/db05-1525","volume":"55","author":"Y Aso","year":"2006","unstructured":"Aso Y, Yamamoto R, Wakabayashi S, Uchida T, Takayanagi K, Takebayashi K et al (2006) Comparison of serum high-molecular-weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 55:1954\u201360","journal-title":"Diabetes"},{"key":"2899_CR16","doi-asserted-by":"crossref","first-page":"e73430","DOI":"10.1371\/journal.pone.0073430","volume":"8","author":"Y Saisho","year":"2013","unstructured":"Saisho Y, Hirose H, Roberts R, Abe T, Kawabe H, Itoh H (2013) C-reactive protein, high-molecular-weight adiponectin and development of metabolic syndrome in the Japanese general population: a longitudinal cohort study. PLoS One 8:e73430","journal-title":"PLoS One"},{"key":"2899_CR17","doi-asserted-by":"crossref","first-page":"e73273","DOI":"10.1371\/journal.pone.0073273","volume":"8","author":"T Eglit","year":"2013","unstructured":"Eglit T, Ringmets I, Lember M (2013) Obesity, high-molecular-weight (HMW) adiponectin, and metabolic risk factors: prevalence and gender-specific associations in Estonia. PLoS One 8:e73273","journal-title":"PLoS One"},{"key":"2899_CR18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1507\/endocrj.EJ12-0277","volume":"60","author":"Y Matsumoto","year":"2013","unstructured":"Matsumoto Y, Toyomasu K, Uchimura N, Ishitake T (2013) Low-molecular-weight adiponectin is more closely associated with episodes of asthma than high-molecular-weight adiponectin. Endocr J 60:119\u201325","journal-title":"Endocr J"},{"key":"2899_CR19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1751-7133.2011.00276.x","volume":"18","author":"SI Negi","year":"2012","unstructured":"Negi SI, Jeong EM, Shukrullah I, Raicu M, Dudley SC Jr (2012) Association of low plasma adiponectin with early diastolic dysfunction. Congest Heart Fail 18:187\u201391","journal-title":"Congest Heart Fail"},{"key":"2899_CR20","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.2174\/092986712803833119","volume":"19","author":"\u00c9 Toussirot","year":"2012","unstructured":"Toussirot \u00c9, Binda D, Gueugnon C, Dumoulin G (2012) Adiponectin in autoimmune diseases. Curr Med Chem 19:5474\u201380","journal-title":"Curr Med Chem"},{"key":"2899_CR21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u201324","journal-title":"Arthritis Rheum"},{"key":"2899_CR22","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K","volume":"41","author":"AM Gestel van","year":"1998","unstructured":"van Gestel AM, Haagsma CJ, van Riel PL (1998) Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845\u201350","journal-title":"Arthritis Rheum"},{"key":"2899_CR23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, Hof MA v 't, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44\u20138","journal-title":"Arthritis Rheum"},{"key":"2899_CR24","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1136\/ard.2005.046540","volume":"65","author":"M Otero","year":"2006","unstructured":"Otero M, Lago R, Gomez R, Lago F, Dieguez C, G\u00f3mez-Reino JJ et al (2006) Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65:1198\u2013201","journal-title":"Ann Rheum Dis"},{"key":"2899_CR25","first-page":"694","volume":"291","author":"N Stefan","year":"2004","unstructured":"Stefan N, H\u00e4ring HU, Stumvoll M (2004) Regulation of synovial adipocytokines. JAMA 291:694\u20135","journal-title":"JAMA"},{"key":"2899_CR26","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/art.24626","volume":"60","author":"YH Rho","year":"2009","unstructured":"Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T et al (2009) Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum 60:1906\u201314","journal-title":"Arthritis Rheum"},{"key":"2899_CR27","first-page":"936","volume":"35","author":"T Nagashima","year":"2008","unstructured":"Nagashima T, Okubo-Fornbacher H, Aoki Y, Kamata Y, Kimura H, Kamimura T et al (2008) Increase in plasma levels of adiponectin after administration of anti-tumor necrosis factor agents in patients with rheumatoid arthritis. J Rheumatol 35:936\u20138","journal-title":"J Rheumatol"},{"key":"2899_CR28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2169\/internalmedicine.50.4306","volume":"50","author":"T Yoshino","year":"2011","unstructured":"Yoshino T, Kusunoki N, Tanaka N, Kaneko K, Kusunoki Y, Endo H et al (2011) Elevated serum levels of resistin, leptin, and adiponectin are associated with C-reactive protein and also other clinical conditions in rheumatoid arthritis. Intern Med 50:269\u201375","journal-title":"Intern Med"},{"key":"2899_CR29","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.3899\/jrheum.080907","volume":"36","author":"TB Laurberg","year":"2009","unstructured":"Laurberg TB, Frystyk J, Ellingsen T, Hansen IT, J\u00f8rgensen A, Tarp U et al (2009) Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls. J Rheumatol 36:1885\u201391","journal-title":"J Rheumatol"},{"key":"2899_CR30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/s10165-007-0605-8","volume":"17","author":"N Komai","year":"2007","unstructured":"Komai N, Morita Y, Sakuta T, Kuwabara A, Kashihara N (2007) Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis. Mod Rheumatol 17:385\u201390","journal-title":"Mod Rheumatol"},{"key":"2899_CR31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10067-008-1074-y","volume":"28","author":"K Ebina","year":"2009","unstructured":"Ebina K, Fukuhara A, Ando W, Hirao M, Koga T, Oshima K et al (2009) Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction. Clin Rheumatol 28:445\u201351","journal-title":"Clin Rheumatol"},{"key":"2899_CR32","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/ard.2005.040857","volume":"65","author":"P H\u00e4rle","year":"2006","unstructured":"H\u00e4rle P, Sarzi-Puttini P, Cutolo M, Straub RH (2006) No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis 65:970\u20131","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2899-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-015-2899-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2899-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T15:26:05Z","timestamp":1566401165000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-015-2899-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,10]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2899"],"URL":"https:\/\/doi.org\/10.1007\/s10067-015-2899-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,10]]}}}